Hemostasis and Blood Group: Complete Notes

RBC Production • Erythrocytes • Hemoglobin • Hemostasis • Blood Groups

CSIR-NET • GATE • DBT • ICMR • MSc Biotechnology

Study Tip: Understand blood physiology as a connected sequence: RBC production → erythrocyte structure → hemoglobin → oxygen transport → vascular injury → platelet response → coagulation → clot formation → clot limitation and repair. For competitive examinations, focus particularly on erythropoiesis, hemoglobin structure and function, platelet plug formation, coagulation pathways, thrombin, fibrin and blood-group antigens.

1. Introduction to Blood and Hemostasis

Blood is a specialized connective tissue that circulates through the cardiovascular system. It performs several essential functions required for maintaining homeostasis. Blood transports oxygen, carbon dioxide, nutrients, hormones, metabolic waste products and various signaling molecules. It also participates in immune defense, temperature regulation and maintenance of acid-base and fluid balance.

Blood consists of a fluid extracellular component called plasma and cellular or formed elements. The major formed elements are erythrocytes, leukocytes and platelets. Erythrocytes are specialized primarily for gas transport, leukocytes participate in defense and immunity, while platelets play a central role in primary hemostasis and contribute to blood clot formation.

Major components of blood

Plasma: The liquid component containing water, electrolytes, proteins, nutrients, hormones and waste products.
Erythrocytes: Red blood cells specialized for oxygen and carbon dioxide transport.
Leukocytes: White blood cells involved in immune and inflammatory responses.
Platelets: Cell fragments derived from megakaryocytes and essential for platelet plug formation and coagulation.

Key Concept: What is Hemostasis?

Hemostasis is the physiological process by which bleeding is stopped after vascular injury while maintaining blood in a fluid state within intact vessels.

Hemostasis involves coordinated interactions among the blood vessel wall, platelets, plasma coagulation proteins and regulatory anticoagulant and fibrinolytic systems.

2. RBC Production / Erythropoiesis

Erythropoiesis is the process through which erythrocytes or red blood cells are produced from hematopoietic stem cells. In healthy adults, the major site of erythropoiesis is the red bone marrow.

RBC production is a highly regulated process because the body must continuously replace erythrocytes that are removed from circulation. Mature human erythrocytes have a limited life span and therefore continuous production is necessary to maintain adequate oxygen-carrying capacity.

Hematopoietic stem cells

Hematopoiesis begins with multipotent hematopoietic stem cells located primarily in the bone marrow in adults. These stem cells can generate different blood-cell lineages.

Hematopoietic stem cells possess self-renewal capacity.
They can differentiate into multiple blood-cell lineages.
Erythroid progenitors eventually give rise to erythrocytes.
Growth factors and cytokines regulate proliferation and differentiation.
Erythropoietin is the major hormonal regulator of erythropoiesis.

Erythropoietin

Erythropoietin (EPO) is a glycoprotein hormone that stimulates erythroid progenitor survival, proliferation and differentiation. In adults, the kidneys are the major source of circulating erythropoietin.

Reduced oxygen availability, or hypoxia, stimulates increased erythropoietin production. Increased EPO signaling promotes RBC production and helps restore oxygen-carrying capacity.

Exam Point:

Hypoxia → increased renal EPO production → stimulation of erythropoiesis → increased RBC production.

Factors required for normal erythropoiesis

Iron for heme synthesis.
Vitamin B₁₂ for normal DNA synthesis and erythroid maturation.
Folate for nucleotide synthesis and cell division.
Adequate amino acids for globin synthesis.
Healthy bone marrow microenvironment.
Erythropoietin and appropriate growth signals.
Functional kidney tissue for appropriate EPO production.

3. Stages of Erythropoiesis

Erythroid differentiation involves a sequence of developmental stages. During maturation, the erythroid cell becomes progressively smaller, hemoglobin content increases, the nucleus condenses and is ultimately expelled.

General sequence

Major cellular changes during erythroid maturation

Cell size generally decreases.
The nucleus becomes progressively condensed.
Hemoglobin concentration increases.
Cytoplasmic staining changes as hemoglobin accumulates.
The nucleus is eventually expelled.
Reticulocytes enter the circulation and mature into erythrocytes.
Mature erythrocytes lack a nucleus and most organelles.

Important:

A reticulocyte is an immature RBC that still contains residual ribosomal RNA. Reticulocyte count can therefore provide information about the activity of erythropoiesis.

4. Erythrocytes: Structure and Functions

Erythrocytes, commonly called red blood cells or RBCs, are the most abundant formed elements of blood. Their major function is transport of oxygen from the respiratory system to tissues and transport of a substantial portion of carbon dioxide from tissues back toward the lungs.

Structural features of mature human RBCs

Mature RBCs are biconcave discs.
They lack a nucleus.
They lack mitochondria.
They lack most other membrane-bound organelles.
They contain large amounts of hemoglobin.
Their flexible membrane allows passage through small blood vessels.
The biconcave shape provides a large surface area relative to volume.

Why is the biconcave shape important?

The biconcave shape increases the surface-area-to-volume relationship of the cell and facilitates efficient gas exchange. It also contributes to flexibility, allowing erythrocytes to deform as they pass through narrow capillaries.

Functions of erythrocytes

Transport oxygen using hemoglobin.
Participate in carbon dioxide transport.
Contribute to blood buffering and acid-base balance.
Help maintain appropriate blood rheological properties.

5. Life Span and Destruction of RBCs

Mature human erythrocytes circulate for approximately 120 days. During this period, they continuously undergo mechanical and metabolic stress.

As RBCs age, their membrane becomes less flexible and their ability to maintain cellular homeostasis decreases. Old or damaged erythrocytes are removed mainly by macrophages of the mononuclear phagocyte system, particularly in the spleen, liver and bone marrow.

Fate of hemoglobin after RBC destruction

Globin chains are broken down into amino acids.
Iron from heme is conserved and recycled.
The porphyrin portion of heme is converted through several steps into bilirubin.
Bilirubin is transported to the liver for further processing.
Iron can be transported and stored for future hemoglobin synthesis.

Exam Point:

RBC destruction is not simply a waste process. A major physiological purpose is recycling of iron and other components of hemoglobin.

6. Hemoglobin

Hemoglobin is the major oxygen-carrying protein of erythrocytes. It is a conjugated protein consisting of globin chains associated with heme groups.

Hemoglobin has an essential role in transporting oxygen from the lungs to tissues. It also participates in carbon dioxide transport and contributes to the buffering capacity of blood.

Major functions of hemoglobin

Transport of oxygen.
Contribution to carbon dioxide transport.
Buffering of hydrogen ions.
Contribution to maintenance of blood acid-base balance.

7. Structure of Hemoglobin

Adult hemoglobin A, commonly written as HbA, is a tetramer composed of two alpha and two beta globin chains: α₂β₂.

Each globin chain is associated with one heme group. The heme contains a porphyrin ring with a central iron ion in the ferrous state (Fe²⁺) under normal functional conditions. This iron is capable of reversibly binding oxygen.

Heme and iron

Heme contains a porphyrin ring.
Iron is located at the center of the heme structure.
Functional hemoglobin normally contains Fe²⁺.
Each hemoglobin molecule can bind up to four oxygen molecules.
Oxygen binding is reversible.

Important exam concept:

Oxidation of the heme iron from Fe²⁺ to Fe³⁺ produces methemoglobin, which does not bind oxygen normally.

8. Hemoglobin and Oxygen Transport

Hemoglobin binds oxygen in the lungs and releases it in peripheral tissues. Oxygen binding to hemoglobin is cooperative, meaning that binding of one oxygen molecule influences the affinity of the remaining heme sites for oxygen.

Oxyhemoglobin and deoxyhemoglobin

Oxyhemoglobin: Hemoglobin with oxygen bound to its heme groups.
Deoxyhemoglobin: Hemoglobin without oxygen bound.

Factors affecting oxygen release

Hemoglobin oxygen affinity changes according to physiological conditions. Increased temperature, increased carbon dioxide, increased hydrogen ion concentration and increased 2,3-BPG generally promote oxygen unloading from hemoglobin in tissues.

Bohr Effect

The Bohr effect describes the reduction in hemoglobin oxygen affinity associated with increased CO₂ and H⁺ concentration. This facilitates oxygen release in metabolically active tissues.

Important hemoglobin types

Hemoglobin	Globin composition	Major significance
HbA	α₂β₂	Major adult hemoglobin
HbA₂	α₂δ₂	Minor adult hemoglobin
HbF	α₂γ₂	Major fetal hemoglobin

Fetal hemoglobin has a higher oxygen affinity than adult hemoglobin, which supports oxygen transfer from maternal blood across the placenta to the fetus.

9. Hemostasis: Introduction

Hemostasis is a tightly regulated physiological response to vascular injury. Its purpose is to prevent excessive blood loss while preserving normal blood flow through intact vessels.

Major stages of hemostasis

Vascular response: Temporary vasoconstriction.
Primary hemostasis: Platelet adhesion, activation and aggregation.
Secondary hemostasis: Activation of coagulation factors and fibrin formation.
Clot stabilization: Formation of a stronger fibrin-supported platelet plug.
Fibrinolysis: Controlled degradation of the clot after repair.

10. Vascular Spasm / Vasoconstriction

Immediately after blood vessel injury, the damaged vessel undergoes constriction. This response decreases local blood flow and therefore helps reduce blood loss.

Mechanisms contributing to vascular constriction

Direct contraction of vascular smooth muscle.
Local nervous responses.
Release of vasoactive substances from damaged tissues.
Platelet-derived mediators contribute to vasoconstriction.

Vasoconstriction is generally temporary and works together with platelet activation and coagulation to produce effective hemostasis.

11. Primary Hemostasis and Platelets

Primary hemostasis is the process in which platelets adhere to the site of vascular injury, become activated and aggregate to form a temporary platelet plug.

Platelet adhesion

Vascular injury exposes subendothelial components, particularly collagen. von Willebrand factor (vWF) plays a major role in platelet adhesion under many conditions by connecting exposed vessel-wall structures with platelet receptors.

Platelet activation

After adhesion, platelets undergo activation. Their shape changes and intracellular signaling causes release or synthesis of mediators that recruit and activate additional platelets.

Platelet aggregation

Activated platelets express or activate receptors that promote platelet aggregation. Fibrinogen can bridge activated platelets and contribute to formation of the platelet plug.

Primary Hemostasis Sequence

Vessel injury → platelet adhesion → platelet activation → platelet aggregation → temporary platelet plug

Important platelet mediators

ADP: Promotes platelet activation and recruitment.
Thromboxane A₂: Promotes platelet activation and vasoconstriction.
Serotonin: Can contribute to vascular responses.
Platelet factor-related activities: Support coagulation and platelet responses.

12. Secondary Hemostasis and Blood Coagulation

Secondary hemostasis involves activation of plasma coagulation factors and ultimately generation of thrombin. Thrombin converts soluble fibrinogen into insoluble fibrin, which forms a mesh that stabilizes the initial platelet plug.

Coagulation factors

The coagulation system involves a series of plasma proteins that become activated sequentially. Many coagulation factors are synthesized in the liver.

Factor	Name	Important point
I	Fibrinogen	Precursor of fibrin
II	Prothrombin	Precursor of thrombin
III	Tissue factor	Important initiator of the extrinsic pathway
IV	Calcium	Essential cofactor in multiple reactions
V	Proaccelerin	Cofactor in prothrombinase complex
VII	Proconvertin	Important in extrinsic pathway
VIII	Antihemophilic factor A	Intrinsic pathway cofactor
IX	Christmas factor	Intrinsic pathway
X	Stuart-Prower factor	Common pathway
XI	Plasma thromboplastin antecedent	Intrinsic pathway
XII	Hageman factor	Intrinsic/contact pathway
XIII	Fibrin-stabilizing factor	Stabilizes fibrin clot

13. Intrinsic, Extrinsic and Common Pathways

The classical coagulation model describes three interconnected components: the intrinsic pathway, extrinsic pathway and common pathway. Both intrinsic and extrinsic pathways converge on activation of factor X and therefore enter the common pathway.

Intrinsic pathway

The classical intrinsic pathway involves factors XII, XI, IX and VIII and ultimately leads to activation of factor X.

Extrinsic pathway

The extrinsic pathway is initiated by tissue factor exposed or released following tissue injury. Tissue factor interacts with factor VII and promotes activation of factor X.

Common pathway

Once factor X is activated, the common pathway proceeds through prothrombinase activity, conversion of prothrombin to thrombin and conversion of fibrinogen into fibrin.

Competitive exam shortcut:

Intrinsic: XII → XI → IX + VIII → X

Extrinsic: Tissue factor + VII → X

Common: X → II → thrombin → I → fibrin

14. Formation of Fibrin Clot

The central enzyme of the common coagulation pathway is thrombin. Thrombin converts soluble fibrinogen into fibrin monomers. These fibrin molecules polymerize to form a network around the platelet plug.

Activated factor XIII contributes to stabilization and cross-linking of the fibrin network, producing a stronger and more stable clot.

Important sequence

Prothrombin → Thrombin → Fibrinogen → Fibrin → Stable Fibrin Clot

Functions of thrombin

Converts fibrinogen to fibrin.
Promotes activation of additional coagulation factors.
Enhances platelet activation.
Participates in amplification of coagulation.

15. Natural Anticoagulant Mechanisms

Hemostasis must remain localized. If coagulation continued without regulation, unnecessary thrombosis could occur. Therefore, the body possesses several anticoagulant mechanisms that limit coagulation to the site and appropriate extent of vascular injury.

Major natural anticoagulant systems

Antithrombin: Inhibits thrombin and several activated coagulation factors.
Protein C and Protein S: Work together as an anticoagulant system that inactivates important cofactors, particularly activated factors V and VIII.
Tissue factor pathway inhibitor: Helps regulate tissue-factor-dependent coagulation.
Intact endothelium: Normally provides an antithrombotic surface and produces substances that inhibit platelet activation and promote vascular homeostasis.

Key idea:

Normal hemostasis is a balance between procoagulant and anticoagulant mechanisms.

16. Fibrinolysis

Once the injured tissue has sufficiently healed, the clot must be removed. This process is called fibrinolysis.

The central enzyme of fibrinolysis is plasmin. Plasmin is generated from its precursor plasminogen by plasminogen activators such as tissue plasminogen activator.

General sequence

Plasminogen → Plasmin → Fibrin degradation → Clot removal

Functions of fibrinolysis

Removes unnecessary fibrin after tissue repair.
Helps restore normal blood flow.
Prevents persistent clot formation.
Maintains the balance between coagulation and clot removal.

17. ABO Blood Group System

The ABO blood group system is one of the most important blood group systems in transfusion medicine. The classification is based primarily on the presence or absence of A and B antigens on the surface of erythrocytes.

ABO antigens and antibodies

Blood Group	RBC Antigen	Major Plasma Antibody
A	A antigen	Anti-B
B	B antigen	Anti-A
AB	A and B antigens	Neither anti-A nor anti-B
O	Neither A nor B	Anti-A and anti-B

Genetics of ABO blood groups

The ABO system is controlled by multiple alleles commonly represented by I^A, I^B and i.

I^A and I^B are codominant.
I^A is dominant over i.
I^B is dominant over i.
i is recessive.

Genotype	Phenotype
I^AI^A	A
I^Ai	A
I^BI^B	B
I^Bi	B
I^AI^B	AB
ii	O

Exam Point:

The AB phenotype results from codominant expression of I^A and I^B. It is not an example of incomplete dominance.

18. Rh Blood Group System

The Rh blood group system is another major blood group system. The D antigen is the most clinically important Rh antigen. Individuals with the D antigen are generally classified as Rh-positive, whereas individuals lacking the D antigen are classified as Rh-negative.

Rh incompatibility

Rh incompatibility can become clinically important during pregnancy when an Rh-negative mother carries an Rh-positive fetus. Exposure to fetal RBCs can lead to maternal sensitization and production of anti-D antibodies.

In subsequent pregnancies, maternal IgG anti-D antibodies can cross the placenta and potentially cause destruction of Rh-positive fetal erythrocytes.

Important Concept

Anti-D immunoglobulin is used clinically to reduce the risk of Rh sensitization in appropriate Rh-negative individuals. This is an important example of prevention of hemolytic disease associated with Rh incompatibility.

19. Blood Transfusion and Compatibility

Blood transfusion requires careful compatibility testing because antibodies in the recipient's plasma can react with antigens on donor erythrocytes. Such reactions may cause agglutination and hemolysis.

ABO RBC compatibility: simplified concept

Recipient	Compatible ABO RBC groups in a simplified setting
A	A and O
B	B and O
AB	A, B, AB and O
O	O

Important:

The terms "universal donor" and "universal recipient" are simplified teaching concepts. Actual transfusion practice depends on component type, Rh status, antibody screening, crossmatching and clinical circumstances.

Blood components

Whole blood: Contains RBCs, plasma and platelets in varying amounts.
Packed RBCs: Primarily used to increase oxygen-carrying capacity.
Platelet components: Used when platelet replacement is indicated.
Fresh frozen plasma: Contains multiple plasma coagulation proteins.
Cryoprecipitate: Contains concentrated amounts of selected plasma proteins, including fibrinogen and factor VIII-related components.

20. Important Comparisons for Competitive Exams

Concept	Meaning	Key Point
Erythropoiesis	Production of RBCs	Major adult site is red bone marrow
Erythrocyte	Mature red blood cell	Transports respiratory gases
Hemoglobin	Oxygen-carrying protein	HbA = α₂β₂
Primary hemostasis	Platelet plug formation	Platelet adhesion, activation and aggregation
Secondary hemostasis	Fibrin formation	Coagulation cascade
Thrombin	Central coagulation enzyme	Converts fibrinogen to fibrin
Fibrin	Structural protein of clot	Stabilizes platelet plug
Fibrinolysis	Clot breakdown	Plasmin degrades fibrin
ABO system	Based on A/B antigens	I^A and I^B codominant
Rh system	Important blood group system	D antigen determines Rh-positive/negative classification

21. Quick Revision Notes

⭐ Must-Remember Points

Erythropoiesis is the process of RBC production.
The major site of erythropoiesis in healthy adults is red bone marrow.
The kidney is the major source of circulating erythropoietin in adults.
Hypoxia stimulates increased erythropoietin production.
EPO promotes survival, proliferation and differentiation of erythroid progenitors.
Iron, vitamin B₁₂, folate and amino acids are important for normal RBC production.
Mature human RBCs are biconcave and lack a nucleus.
Mature RBCs lack mitochondria and therefore rely heavily on glycolysis for ATP production.
The approximate life span of a circulating human RBC is 120 days.
Hemoglobin is the major oxygen-carrying protein in RBCs.
HbA consists mainly of α₂β₂.
Each hemoglobin molecule contains four heme groups.
Each heme contains an iron atom capable of reversibly binding oxygen.
Hemoglobin also contributes to carbon dioxide transport and buffering.
Hemostasis prevents excessive bleeding while maintaining blood fluidity in intact vessels.
Vasoconstriction is an early vascular response to injury.
Primary hemostasis produces a temporary platelet plug.
Platelet adhesion involves an important role for von Willebrand factor.
Secondary hemostasis produces fibrin that stabilizes the platelet plug.
Thrombin converts fibrinogen into fibrin.
Factor X is the major convergence point of the classical intrinsic and extrinsic pathways.
Factor VII is strongly associated with the extrinsic pathway.
Factors XII, XI, IX and VIII are associated with the classical intrinsic pathway.
Factor XIII contributes to fibrin stabilization.
Plasmin is the major enzyme responsible for fibrin degradation during fibrinolysis.
In ABO blood groups, group A has A antigen and anti-B antibody.
Group B has B antigen and anti-A antibody.
Group AB has both A and B antigens and normally lacks anti-A and anti-B antibodies.
Group O has neither A nor B antigen but has anti-A and anti-B antibodies.
I^A and I^B are codominant alleles.
The i allele is recessive to I^A and I^B.
The D antigen is the most clinically important antigen of the Rh system.
Rh-positive individuals possess the D antigen.
Rh incompatibility can lead to maternal sensitization and hemolytic disease of the fetus and newborn.

23. Final Exam-Oriented Summary

Hemostasis and blood physiology can be understood as a connected sequence of cellular, molecular and biochemical events. RBCs are continuously produced through erythropoiesis to maintain oxygen transport. Erythropoietin is a major regulator of RBC production, particularly in response to hypoxia.

Erythropoiesis: Production of red blood cells.
Major adult site: Red bone marrow.
Main hormonal regulator: Erythropoietin.
RBC structure: Biconcave, flexible and anucleate in mature humans.
RBC life span: Approximately 120 days.
Hemoglobin: Major oxygen-carrying protein of RBCs.
HbA: α₂β₂.
Primary hemostasis: Platelet plug formation.
Secondary hemostasis: Fibrin formation through coagulation.
Thrombin: Converts fibrinogen to fibrin.
Factor X: Major convergence point of the classical intrinsic and extrinsic pathways.
Fibrinolysis: Removal of fibrin clot.
Plasmin: Major fibrin-degrading enzyme.
ABO system: Based on A and B antigens and corresponding antibodies.
I^A and I^B: Codominant alleles.
Rh-positive: Presence of D antigen.

For CSIR-NET, GATE Biotechnology, DBT-BET, ICMR-JRF and MSc-level examinations, special attention should be given to the sequence of erythropoiesis, structure of hemoglobin, EPO regulation, platelet functions, intrinsic and extrinsic coagulation pathways, thrombin and fibrin formation, fibrinolysis and ABO/Rh blood-group inheritance.

Home

Sunday, 23 August 2026